Dr Mark N Lee, MD, PHD | |
20 York St, New Haven, CT 06510-3220 | |
(617) 820-0262 | |
Not Available |
Full Name | Dr Mark N Lee |
---|---|
Gender | Male |
Speciality | Pathology - Blood Banking & Transfusion Medicine |
Location | 20 York St, New Haven, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497139034 | NPI | - | NPPES |
Entity Name | Massachusetts General Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Treating maternal psychiatric disorder with commonly used antidepressants is associated with a lower risk of certain pregnancy complications including preterm birth and delivery by Caesarean section, according to researchers at Columbia University's Mailman School of Public Health, Columbia University Medical Center, and the New York State Psychiatric Institute. However, the medications - selective serotonin reuptake inhibitors, or SSRIs - resulted in an increased risk of neonatal problems.
Pregnant women can be protected from malaria, a major cause of prematurity, low birth weight and death in infants in Africa, with dihydroartemisinin-piperaquine , an artemisinin combination therapy that is already widely used to treat malaria in adults, according to a study by researchers at UC San Francisco and in Uganda.
› Verified 3 days ago
Entity Name | The General Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Treating maternal psychiatric disorder with commonly used antidepressants is associated with a lower risk of certain pregnancy complications including preterm birth and delivery by Caesarean section, according to researchers at Columbia University's Mailman School of Public Health, Columbia University Medical Center, and the New York State Psychiatric Institute. However, the medications - selective serotonin reuptake inhibitors, or SSRIs - resulted in an increased risk of neonatal problems.
Pregnant women can be protected from malaria, a major cause of prematurity, low birth weight and death in infants in Africa, with dihydroartemisinin-piperaquine , an artemisinin combination therapy that is already widely used to treat malaria in adults, according to a study by researchers at UC San Francisco and in Uganda.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark N Lee, MD, PHD 789 Howard Ave Bldg 441, New Haven, CT 06519-1304 Ph: (617) 820-0262 | Dr Mark N Lee, MD, PHD 20 York St, New Haven, CT 06510-3220 Ph: (617) 820-0262 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
Treating maternal psychiatric disorder with commonly used antidepressants is associated with a lower risk of certain pregnancy complications including preterm birth and delivery by Caesarean section, according to researchers at Columbia University's Mailman School of Public Health, Columbia University Medical Center, and the New York State Psychiatric Institute. However, the medications - selective serotonin reuptake inhibitors, or SSRIs - resulted in an increased risk of neonatal problems.
Pregnant women can be protected from malaria, a major cause of prematurity, low birth weight and death in infants in Africa, with dihydroartemisinin-piperaquine , an artemisinin combination therapy that is already widely used to treat malaria in adults, according to a study by researchers at UC San Francisco and in Uganda.
› Verified 3 days ago
Dr. Barton Charles Kenney, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Edward S Lee, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Melissa Anne Much, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York St # T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Haris Mirza, MD Pathology Medicare: Medicare Enrolled Practice Location: Yale School Of Medicine, Dept. Of Pathology, 20 York St, New Haven, CT 06510 Phone: 877-925-3522 Fax: 203-737-5388 | |
Raffaella Morotti, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 310 Cedar St, Pathology Department, New Haven, CT 06510 Phone: 203-737-6325 | |
Dr. Richard Rodion Rathbone, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, Yale-new Haven Hospital, New Haven, CT 06504 Phone: 203-688-2439 Fax: 203-688-5103 | |
Dr. Mahboubeh Rahmani, MD Pathology Medicare: Medicare Enrolled Practice Location: 310 Cedar St, New Haven, CT 06510 Phone: 203-737-2115 |